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of the myocardial resting membrane potential (E
m
).1
The extracellular potassium concentration is an impor-
tant determinant of the E
m
, and this relationship is
exploited by hyperkalemic preservation solutions, used
W ithin seconds of the onset of an unprotected peri-od of ischemia, extracellular potassium (K+
e
)
begins to accumulate in a characteristic triphasic man-
ner and is associated with a concomitant depolarization
Objectives: We previously demonstrated improved myocardial preserva-
tion with polarized (tetrodotoxin-induced), compared with depolarized
(hyperkalemia-induced), arrest and hypothermic storage. This study
was undertaken to determine whether polarized arrest reduced ionic
imbalance during ischemic storage and whether this was influenced by
Na+/K+/2Cl– cotransport inhibition. Methods: We used the isolated crys-
talloid perfused working rat heart preparation (1) to measure extracel-
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during ischemic (control), depolarized (K+ 16 mmol/L), and polarized
(tetrodotoxin, 22 m mol/L) arrest and hypothermic (7.5°C) storage (5
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effects of the Na+/K+/2Cl– cotransport inhibitor, furosemide, on extra-
cellular K+ accumulation during polarized arrest and 7.5°C storage, and
(3) to correlate extracellular K+ accumulation to postischemic recovery
of cardiac function. Results: Characteristic triphasic profiles of extracel-
lular K+ accumulation were observed in control and depolarized arrest-
ed hearts; a significantly attenuated profile with polarized arrested
hearts demonstrated reduced extracellular K+ accumulation, correlat-
ing with higher postischemic function (recovery of aortic flow was 54%
± 4% [P = .01] compared with 39% ± 3% and 32% ± 3% in depolarized
and control hearts, respectively). Furosemide (0.1, 1.0, 10, and 100
m mol/L) modified extracellular K+ accumulation by –18%, –38%,
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was associated with a reduced ionic imbalance (demonstrated by
reduced extracellular K+ accumulation) and improved recovery of car-
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for cardioplegic arrest and long-term hypothermic stor-
age of the heart during clinical transplantation. Infusion
of these solutions induces a rapid K+-induced depolar-
ization of the E
m
and a flaccid diastolic arrest.
However, hyperkalemia-induced depolarization of the
resting E
m
may predispose the myocardium to the accu-
mulation of intracellular sodium (Na+i)2 via activation
of the sodium “window current” (INaw). We3 have pre-
viously shown that, during 5 hours of global hypother-
mic (7.5°C) ischemic storage, a solution containing a
16-mmol/L concentration of K+ depolarizes and main-
tains the E
m
of hearts at approximately –50 mV; inas-
much as this is within the required voltage range (–65
to –15 mV) for activation of INaw, it is likely that INaw
would become activated, supporting the evidence that
this current may be involved in the pathogenesis of
ischemia and reperfusion injury.4 Hyperkalemia may
also predispose the myocardium to calcium accumula-
tion via activation of a voltage-dependent calcium
“window current” (ICaw),5 and this is supported in stud-
ies by Lopéz and colleagues,6 who have demonstrated
that isolated myocytes exposed to a 16-mmol/L con-
centration of K+ rapidly accumulate calcium. 
In contrast, preservation solutions that are formulated
to maintain the myocardial E
m
close to the resting level
of approximately –80 mV in a more polarized state3
may prevent the activation of INaw and ICaw. At this volt-
age, Ca2+ and Na+ channels should be in a closed state
and the driving force for potassium ions greatly
reduced as the E
m 
is close to the reversal potential for
potassium (EK). Therefore, a polarized Em should lead
to an attenuation of ionic imbalance, including Na+i,7
Ca2+i,6 and K+e accumulation, and thereby reduce meta-
bolic demand8; this should prove to be more beneficial
to the ischemic myocardium.3
Profound hypothermia during ischemia has been
shown to be associated with large increases in Na+i.9 The
Na+/K+/2Cl– cotransporter has been implicated as one of
several possible routes involved in the observed sodium
overload.10 Furosemide, a loop diuretic that has been
shown to inhibit this cotransport pathway, may prove to
be of benefit to the postischemic myocardium11; howev-
er, inhibition may also cause a concomitant elevation of
K+
e
, resulting from the unidirectional nature of the
Na+/K+/2Cl– cotransporter.12 The effects of Na+/K+/2Cl–
cotransport inhibition on K+
e
accumulation during
hypothermic ischemic storage are largely unknown. 
Therefore, the objectives of this study were (1) to
investigate K+
e
accumulation during ischemic, high
K+–induced (depolarized) and tetrodotoxin-induced
(polarized) arrest and hypothermic storage, (2) to deter-
mine the dose-dependent effects of Na+/K+/2Cl– cotrans-
port inhibition on K+
e
accumulation during tetrodotoxin-
induced (polarized) arrest and hypothermic storage, and
(3) to correlate any changes in K+
e
accumulation to the
recovery of postischemic cardiac function.
Materials and methods
Animals. Hearts were obtained from male Wistar rats
(Bantin and Kingman Ltd, Hull, United Kingdom) weighing
200 to 250 g. All animals received humane care in accordance
with the “Guidance on the Operation of the Animals
(Scientific Procedures) Act 1986,” published by Her
Majesty’s Stationery Office, London, England.
Experimental preparation. The isolated perfused work-
ing rat heart preparation was used for this study. In brief, it is
a left-sided heart preparation in which oxygenated Krebs-
Henseleit perfusion buffer (at 37°C) enters the cannulated left
atrium at a pressure equivalent to 20 cm H2O. The perfusate
passes to the left ventricle, from which it is spontaneously
ejected through an aortic cannula against a hydrostatic pres-
sure equivalent to 100 cm H2O. Exclusion criteria imposed in
this study rejected hearts that produced an aortic flow less
than 50 mL/min or a coronary flow in excess of 26 mL/min
after 20 minutes of the control (preischemic) working period.
Coronary flow from the right side of the heart can be sampled
for enzyme analysis or pooled and recirculated with the aor-
tic outflow. The Krebs-Henseleit bicarbonate perfusion buffer
contained (in millimoles per liter) NaCl 119, NaHCO3 25,
KCl 4.75, MgSO4 1.2, KH2PO4 1.18, CaCl2 1.4, and glucose
11.1 at a pH of 7.4 when gassed with 95% oxygen and 5%
carbon dioxide at 37°C (see Table I for detailed composition).
This solution was filtered through a 5- m m porosity cellulose
nitrate filter before use and was continually passed through
an in-line 5-m m porosity filter during the working period of
the study. The filter was changed before the reperfusion
working period.
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Table I. Composition of solutions used to compare
K+
e
accumulation during depolarized and polarized
long-term hypothermic preservation and subsequent
postischemic recovery of cardiac function
Constituent Control Depolarized Polarized 
(mmol/L) (KH buffer) (high K+) (TTX)
Na+ 144 144 144
K+ 5.9 16.0 5.9
Cl– 127 142 127
Mg2+ 1.2 1.2 1.2
Ca2+ 1.4 1.4 1.4
HCO3– 25 25 25
H2PO4– 1.2 1.2 1.2
SO42– 1.2 1.2 1.2
Glucose 11.1 11.1 11.1
TTX (m mol/L) — — 22
pH at 7.5°C 8.3 8.2 8.3
KH, Krebs-Henseleit; TTX, tetrodotoxin.
During the hypothermic storage period, each heart was
maintained in a sealed temperature-controlled heart chamber
at 7.5°C.
Perfusion protocol. After cannulation of the aorta, the
heart was perfused with Krebs-Henseleit buffer in the
Langendorff mode for a 5-minute stabilization period. During
this stabilization period, the pulmonary artery was cut and the
pulmonary veins to the left atrium were cannulated. The heart
was then converted to working mode perfusion, and preis-
chemic (control) cardiac function (aortic flow, aortic pres-
sure, heart rate, coronary flow, and cardiac output) was deter-
mined during two 10-minute periods of working mode
perfusion; this was interspersed with a 5-minute period of
Langendorff mode perfusion (Fig 1, A and B) when the K+-
sensitive electrode (Fig 2) was stitched into the myocardium. 
Two studies were conducted:
Study A: Depolarized versus polarized storage. To compare
the effects of ischemic arrest, high K+ (depolarized) arrest,
and tetrodotoxin-induced (polarized) arrest and storage on K+
e
accumulation, hearts were infused (over 30 seconds) with 2
mL of either Krebs-Henseleit (control) buffer, Krebs-
Henseleit buffer + 16 mmol/L K+, or Krebs-Henseleit buffer +
22 m mol/L tetrodotoxin via a self-sealing multi-injection port
at 21°C (Fig 1, A). This volume and rate of delivery had pre-
viously been determined as the optimum in terms of function-
al recovery in the rat heart. Individual hearts were then stored
for 5 hours in separate chambers containing 9 mL of the
arresting solution (Krebs-Henseleit buffer, Krebs-Henseleit
buffer + 16 mmol/L K+, or Krebs-Henseleit buffer + 22
m mol/L tetrodotoxin) so that the heart (with electrodes in
place) was totally immersed in the hypothermic (7.5°C) stor-
age solution for 5 hours (see Table I for arrest/storage solution
composition). 
Study B: Inhibition of Na+/K+/2Cl– cotransport during
polarized storage. Furosemide (Sigma-Aldrich, Dorset,
United Kingdom), a Na+/K+/2Cl– cotransport inhibitor, was
dissolved in methanol, and different concentrations of stock
solutions were kept at 4°C for 5 days; the final methanol con-
centration in the storage solution was 0.1% in all groups of
study B. To investigate the effects of the Na+/K+/2Cl– cotrans-
port inhibitor furosemide on K+
e
accumulation during polar-
ized arrest and storage, hearts were infused (over 30 seconds)
with 2 mL of Krebs-Henseleit buffer + 22 m mol/L tetrodotox-
in + 0.1% methanol (control) or control + 0.1, 1.0, 10, or 100
m mol/L furosemide via a self-sealing multi-injection port at
21°C (see Fig 1, B). Individual hearts were then stored for 5
hours in separate chambers containing 9 mL of the arresting
solution (Krebs-Henseleit buffer + 22 m mol/L tetrodotoxin +
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Fig 1. The experimental protocols for study A and study B are represented diagrammatically. The arrows indi-
cate the stage during the protocol at which the electrodes were inserted into the myocardium. LM, Langendorff
mode; WM, working mode; CI, cardioplegic infusion; KH, Krebs-Henseleit; TTX, tetrodotoxin.
0.1% methanol [control] or control + 0.1, 1.0, 10, or 100
m mol/L furosemide) so that the heart (with electrodes in
place) was totally immersed in the hypothermic (7.5°C) stor-
age solution for 5 hours (see Table II for arrest/storage solu-
tion composition). K+
e
was continuously monitored through-
out the storage period and the signal was captured by using a
purpose-built electrode amplifier and passed through a 1.0-
Hz low-pass filter, displayed on a digital storage oscilloscope
(Gould model 1425, Gould, Inc, Oxnard, Calif) and recorded
on a chart recorder (Gould model RS 3200). 
Postischemic analysis. After storage, all hearts in study A
and 8 hearts per group in study B were reperfused with
Krebs-Henseleit buffer, initially in the Langendorff mode for
15 minutes and then in the working mode for a further 30
minutes. During working mode reperfusion, recovery of
postischemic cardiac function was determined and expressed
as a percentage of the averaged cardiac function measured
before and after electrode insertion, during preischemic
working mode perfusion. In study B, hearts (n = 4) that were
used for K+
e
measurement were freeze-clamped at the end of
the storage period for analysis of tissue water content. 
Potassium mini-electrode preparation. Potassium sensi-
tive “end-window” mini-electrodes, incorporating a poly-
vinyl chloride (PVC)/valinomycin membrane, were first used
by Hill and coworkers13 for the on-line measurement of
myocardial and intravascular potassium concentration. In this
study, this “end-window” electrode configuration was re-
placed by an alternative “side-window” configuration, there-
by improving the electrode sensor for measurement of
intramyocardial potassium. Our side-window configuration
(Fig 2) allowed the electrodes to be stitched into the
myocardium, eliminating the possibility of the electrode
becoming dislodged by movement of the heart during aerobic
perfusion and reperfusion. These electrodes were used to
measure intramyocardial K+
e
accumulation as an index of
ionic imbalance during (1) unprotected ischemia, high K+,
and tetrodotoxin-induced arrest and storage and (2)
tetrodotoxin-induced polarized arrest combined with
Na+/K+/2Cl– cotransport inhibition, in hearts subjected to
long-term preservation.
Preparation of PVC/valinomycin ion–selective membrane
for the “side-window” electrode. The electrode matrix con-
sisted of a PVC/valinomycin mixture containing 2.0 mg vali-
nomycin, 0.5 mg potassium tetrakis (4-chlorophenyl borate),
150 mg bis(2-ethylhexyl) sebacate, and 66.0 mg PVC (mole-
cular weight 200,000) dissolved in 4 mL of tetrahydrofuran.
All chemicals were obtained from Fluka Chemicals (Sigma-
Aldrich Corporation, St Louis, Mo). The mixture was stirred
for 2 hours at room temperature and then allowed to stand
unsealed for 48 hours at room temperature to allow the
tetrahydrofuran to evaporate. 
Electrodes for the measurement of K+
e
were prepared from
PVC tubing with a 1.0 mm inner diameter · 1.6 mm outer
diameter (Portex Ltd, United Kingdom) pulled to a taper over
a Bunsen flame. The lumen of the PVC tube was then exam-
ined under a low-power microscope (· 30 magnification) and,
if wide enough (>0.25 mm) for a piece of silk to be inserted
down the lumen, the PVC tube was trimmed to a length of
approximately 10 cm for the next stage. A small amount of
126 Snabaitis, Shattock, Chambers The Journal of Thoracic and
Cardiovascular Surgery
July 1999
Fig 2. Diagrammatic representation of a cross section
through a “side-window” PVC/valinomycin electrode, show-
ing the electrode stitched into the left ventricular wall (LVW)
for on-line determination of myocardial K+
e
during long-term
preservation. 
Table II. Composition of solutions used to study the
dose-dependent effect of furosemide on K+
e
accumula-
tion during polarized arrest and storage and subsequent
postischemic recovery of cardiac function
Group Group Group Group 
Constituent Control I II II IV
Na+ (mmol/L) 144 144 144 144 144
K+ (mmol/L) 5.9 5.9 5.9 5.9 5.9
Cl– (mmol/L) 127 127 127 127 127
Mg2+ (mmol/L) 1.2 1.2 1.2 1.2 1.2
Ca2+ (mmol/L) 1.4 1.4 1.4 1.4 1.4
HCO3– (mmol/L) 25 25 25 25 25
H2PO4– (mmol/L) 1.2 1.2 1.2 1.2 1.2
SO42– (mmol/L) 1.2 1.2 1.2 1.2 1.2
Glucose (mmol/L) 11.1 11.1 11.1 11.1 11.1
TTX m mol/L 22 22 22 22 22
Methanol (%) 0.1 0.1 0.1 0.1 0.1
Furosemide — 0.1 1.0 10 100
(m mol/L)
pH at 7.5°C 8.3 8.3 8.3 8.3 8.3
KH, Krebs-Henseleit; TTX, tetrodotoxin.
epoxy resin was sucked into the tapered end to a distance of
5 mm and allowed to dry. The tapered end of the PVC tube
was bent back and a small portion of the side wall of the tub-
ing was cut away with a scalpel blade to leave a “window” in
the side of the electrode. Through this window a piece of 8-0
or 6-0 silk (Mersilk, Ethicon Ltd) was passed up toward the
wider end of the PVC tube. A small (1 mm) collar of silicone
rubber tubing was positioned behind the window on the PVC
tubing to act as a stop during electrode insertion (Fig 2). 
The electrode was filled with a solution of KCl 4.0, NaCl
146, CaCl2 1.4, and MgCl2 1.2 (in millimoles per liter). The
PVC matrix was then redissolved in 750 m L of tetrahydrofu-
ran and, using a clean glass rod, a small amount of the
PVC/valinomycin matrix was coated over the side window to
form a membrane. Two coats of the PVC/valinomycin matrix
were applied to obtain a complete and robust covering of the
window. The electrodes were prepared 24 hours before use
and stored in a solution identical to the electrode filling solu-
tion. A syringe needle was attached to the end of the electrode
with cyanoacrylate adhesive. 
Calibration of electrodes. Pre-experiment calibration of the
potassium electrodes was performed at both 7.5°C and 37°C
in solutions containing potassium concentrations (in mil-
limoles per liter) of 4, 5.93 (the same as Krebs-Henseleit
buffer), 16, and 32 (where total K+ + Na+ = 150 mmol/L),
CaCl2 1.2, and MgCl2 1.2; electrodes responded in a
Nernstian manner at both 7.5°C (54.8 ± 0.3 mV/decade) and
37°C (60.5 ± 0.3 mV/decade). At the end of an experimental
protocol, the potassium electrodes were recalibrated in the
same solutions at both 7.5°C (55.6 ± 0.4 mV/decade) and
37°C (60.6 ± 0.3 mV/decade) to ensure that the electrodes
were undamaged during the experiment and functioning sat-
isfactorily; experiments were discarded if the difference
between the pre-experiment and post-experiment calibration
at 37°C was more than 1 mV. To test whether electrodes
behaved similarly during pre-experiment calibration and
when stitched into the heart, in vitro calibration of the elec-
trodes was performed by perfusing the heart with Krebs-
Henseleit–based solutions at 37°C (59.5 ± 0.8 mV/decade)
containing KCl at concentrations of 4, 5.93 (the same as
Krebs-Henseleit solution), 16, and 32 mmol/L at the end of
the protocol. The selectivity of the potassium electrodes over
sodium (KK-Napot) at 7.5°C and 37°C was determined to be
0.0019 and 0.0034, respectively, by measuring the voltage
difference (Vdiff) induced when increasing the concentration
of the principal interfering ion (Na+) from 140 mmol/L to 170
mmol/L while keeping the K+ concentration constant at 0.4
mmol/L. The time taken for electrodes to respond and
achieve steady state after immersion in a 4 mmol/L K+ cali-
bration solution was 0.90 ± 0.04 second at 7.5°C and 0.86 ±
0.04 second at 37°C. 
Myocardial water content. In those hearts that were
freeze-clamped at the end of storage (study B), percentage
water content of ventricular biopsy specimens was calculated
by the relative change in biopsy weight after drying in an
oven for 24 hours at 80°C.
Statistical analysis. Hearts were randomized into appro-
priate groups before experiments by means of a computerized
randomization procedure. In study A, there were 6 hearts per
group; in study B, 12 hearts per group were used to determine
(1) the effects of furosemide on K+
e
accumulation (4 hearts
per group) and (2) the recovery of cardiac function (8 hearts
per group) after tetrodotoxin-induced (polarized) arrest. All
data are presented as mean ± standard error of the mean. 
Preischemic cardiac function, measured during two periods
of 10-minute working mode perfusion (see Fig 1), were com-
pared by a paired 1-tailed Student t test to determine the
effect of electrode insertion. To determine differences in
recovery of function between groups, data were subjected to
analyses by a 1-way analysis of variance and, if statistical sig-
nificance was achieved, Dunnett’s (for group vs control com-
parison) and Tukey’s (for group vs group comparison) modi-
fied t tests (to account for multiple comparisons) were used.
Differences were considered significant at the 95% confi-
dence limit. All statistical analysis was conducted on a
Macintosh microcomputer using Statview SE + Graphics
(version 1.03, Abacus Concepts Inc, Berkeley, Calif).
Results
Study A
K+
e
accumulation during ischemic arrest, high K+
arrest, and tetrodotoxin arrest and storage. The rela-
tionship between K+
e
accumulation and ischemic dura-
tion in control hearts (ischemic arrest) and hearts arrest-
ed with either 16-mmol/L K+ (high K+) or 22-m mol/L
tetrodotoxin is shown in Fig 3, A. Baseline K+
e
was 5.93
mmol/L (ie, the potassium concentration in Krebs-
Henseleit buffer perfusate before the onset of ischemia).
From the onset of ischemia, K+
e
accumulated during
hypothermic storage in a typical triphasic profile in all
groups; in the control group of hearts, K+
e
increased to
an initial (phase 1) peak of 11.2 ± 0.7 mmol/L after 15
minutes and decreased to 9.6 ± 0.6 mmol/L after 75
minutes (during phase 2) before increasing a second
time to a peak of 20.5 ± 2.7 mmol/L (during phase 3)
immediately before reperfusion. Infusion of hearts for
30 seconds with Krebs-Henseleit buffer containing high
K+ (at a final concentration of 16 mmol/L) rapidly
increased the K+
e
to 16.3 ± 0.4 mmol/L (Fig 3, A).
During ischemia, K+
e
increased further to an initial peak
of 18.8 ± 4.8 mmol/L at 20 minutes during phase 1, then
decreased during phase 2 to 16.6 ± 2.0 mmol/L after 90
minutes, before again increasing to 32.2 ± 3.6 mmol/L
during phase 3, before reperfusion. In tetrodotoxin-
treated hearts, peak K+
e
accumulation during phase 1
was delayed to 45 minutes and had risen to only 8.8 ±
0.4 mmol/L. There was a slight decrease to 8.4 ± 1.9
mmol/L after 105 minutes during phase 2 before K+
e
accumulation increased to 14.1 ± 1.7 mmol/L during
phase 3, before reperfusion (Fig 3, A). 
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Rate of K+
e
accumulation during high K+– and
tetrodotoxin-induced arrest and storage. The rate of
change in K+
e
accumulation during ischemic storage is
shown in Fig 4, A; the most rapid rate of increase in K+
e
in the control group (0.9 ± 0.3 mmol/L per minute)
occurred during the second minute of ischemia. In con-
trast, the most rapid rate of K+
e
accumulation in the
high K+–treated and tetrodotoxin-treated groups was
0.5 ± 0.3 and 0.3 ± 0.1 mmol/L per minute, respective-
ly, and occurred during the fourth minute after the
onset of ischemia.
Recovery of function after ischemic arrest, high K+
arrest, or tetrodotoxin arrest and storage. Preischemic
cardiac function did not differ before and after elec-
trode insertion in each group (see Fig 1); consequently,
the mean of the combined data for each heart over the
20-minute working mode perfusion period was used to
determine percentage recovery and subsequent mean
values (Table III). Aortic flow recovered to 54% ± 4%
in the tetrodotoxin-treated hearts, and this was signifi-
cantly (P = 0.01) higher than in the control (32% ± 4%)
and the high K+ (39% ± 3%) groups of hearts (Fig 5,
A). Other indices of cardiac function (aortic pressure,
heart rate, coronary flow, cardiac output, stroke vol-
ume, and stroke work) were also measured for all
groups, and the recovery of these indices and for aortic
flow is shown in Table III.
Study B
Effect of furosemide on K+
e
accumulation during
polarized arrest and storage. The profiles of myocardial
K+
e
accumulation in the control solution (Krebs-
Henseleit buffer + 22 m mol/L tetrodotoxin) and addition
of 0.1, 1.0, 10, or 100 m mol/L furosemide to the control
solution are shown in Fig 3, B. After the onset of
ischemia in the control group (Krebs-Henseleit buffer +
22 m mol/L tetrodotoxin + drug vehicle [0.1%
methanol]), K+
e
during phase 1 increased to a peak of
13.3 ± 2.6 mmol/L after 30 minutes. Myocardial K+
e
then decreased to 11.7 ± 1.7 mmol/L during phase 2
before increasing to 13.1 ± 1.8 mmol/L at the end of stor-
age during phase 3. In hearts treated with 0.1, 1.0, 10, and
100 m mol/L furosemide, peak K+
e
accumulation dur-
ing phase 1 was 10.9 ± 1.0, 8.4 ± 0.8, 13.7 ± 2.6, and 14.5
± 2.2 mmol/L, respectively. During phase 2, K+
e
decreased to 9.8 ± 0.2, 7.8 ± 0.4, 12.9 ± 2.3, and 13.6 ±
1.4 mmol/L before increasing to 12.7 ± 1.1, 9.6 ± 0.2,
17.1 ± 2.9, and 18.6 ± 3.2 mmol/L, respectively, at the
end of phase 3. Furosemide (0.1 and 1.0 m mol/L) reduced
the total K+
e
accumulation (area under curve) by 28%
and 65% (P = .02 vs control group for both), whereas
higher concentrations (10 and 100 m mol/L) increased
total K+
e
accumulation by 23% and 40%, respectively.
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Fig 3. All hearts were initially perfused in the working mode
for 10 minutes before cardioplegic arrest and hypothermic
(7.5°C) storage for 5 hours. Changes in myocardial K+
e
(mmol/L) were then determined with potassium-sensitive
“side-window” flexible electrodes. A, Hearts were arrested
and stored with Krebs-Henseleit buffer alone (control: open
circles), high K+ (open squares), or tetrodotoxin (filled cir-
cles). Arrow indicates onset of reperfusion; n = 6 hearts per
group. B, Hearts were arrested and stored with Krebs-
Henseleit buffer + 22 m mol/L tetrodotoxin + 0.1% methanol
(control; filled circles), control + 0.1 m mol/L (open squares),
1.0 m mol/L (filled squares), 10 m mol/L (open triangles), and
100 m mol/L (filled triangles) furosemide; n = 4 hearts per
group. Arrow indicates time of freeze-clamping of hearts for
tissue weight determination. All values represent the mean ±
standard error of mean; baseline K+
e
during preischemic aer-
obic perfusion and postischemic reperfusion was equal to that
of the Krebs-Henseleit buffer perfusate (5.93 mmol/L).
Effect of furosemide on rate of K+
e
accumulation dur-
ing polarized arrest and storage. The rate of K+
e
accu-
mulation during the first 30 minutes of storage in the
control group and the 0.1, 1.0, 10, and 100 m mol/L
furosemide-treated groups are shown in Fig 4, B. The
peak rate of K+
e
accumulation was 1.01 ± 0.4, 0.9 ±
0.2, 0.4 ± 0.2, 1.3 ± 0.4, and 0.7 ± 0.3 mmol/L per
minute, respectively, and occurred during the first 2
minutes of ischemia. 
Myocardial water content. There were no differences
in tissue water content between control (83.7% ± 0.7%)
and 0.1 (82.9% ± 0.7%), 1.0 (83.4% ± 0.7%), 10
(81.8% ± 0.7%), and 100 m mol/L (83.6% ± 0.2%)
furosemide-treated hearts after 5 hours of storage. 
Effect of furosemide on recovery of function after
polarized arrest and storage. Preischemic cardiac func-
tion did not differ before and after electrode insertion;
thus preischemic cardiac function measurements were
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Fig 4. A, Rate of change in myocardial K+
e
during 5 hours of hypothermic (7.5°C) ischemic storage in hearts
arrested and stored with Krebs-Henseleit buffer alone (control; open circles), high K+ (open squares), or
tetrodotoxin (filled circles). Values represent the mean of 6 hearts per group; standard errors have been omitted
for clarity. Note the change in scale along the time axis between 0-60 and 60-300 minutes. B, Rate of change in
myocardial K+
e
during 5 hours of hypothermic (7.5°C) ischemic storage of hearts arrested and stored with Krebs-
Henseleit buffer + 22 m mol/L tetrodotoxin + 0.1% methanol (control; filled circles) or control + 0.1 m mol/L (open
squares), 1.0 m mol/L (filled squares), 10 m mol/L (open triangles), and 100 m mol/L (filled triangles) furosemide.
Values represent the mean of n = 4 hearts per group; standard errors have been omitted for clarity. Note the change
in scale along the time axis between 0-60 and 60-300 minutes.
averaged (Table IV). Fig 5, B, shows the postischemic
recovery of aortic flow after 5 hours of ischemic
(7.5°C) storage. Recovery of aortic flow in the vehicle
control and the 0.1, 1.0, 10, and 100 m mol/L
furosemide-treated groups was 53% ± 4%, 56% ± 8%,
70% ± 2% (P = .04 vs control), 69% ± 4% (P = .04 vs
control), and 65% ± 3% (P = .04 vs control), respec-
tively. Recovery of other functional parameters (aortic
pressure, heart rate, coronary flow, cardiac output,
stroke volume, and stroke work) for all groups is shown
in Table IV. Similar recovery profiles were observed
with cardiac output, stroke volume, and stroke work.
Heart rate, coronary flow, and aortic pressure recovered
to similar values in all groups.
Discussion
Ischemia and K+e. Many studies have shown that K+e
increases rapidly within seconds of the onset of
ischemia and that there is a “typical” triphasic profile of
K+
e
accumulation. After an initial rapid rise (phase 1),
there is an intermediate phase (phase 2) in which K+
e
either plateaus14 or declines,15 and this is followed by a
secondary increase in K+
e
(phase 3). In our control
group of hearts (study A), the K+
e
profile was charac-
teristically triphasic with a decline during the interme-
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Fig 5. A, Postischemic recovery of aortic flow after 30 min-
utes of working mode reperfusion after K+
e
determination
during 5 hours of hypothermic (7.5°C) ischemic arrest and
storage with either Krebs-Henseleit buffer alone (control) or
high K+ and tetrodotoxin. Values are expressed as a percent
of preischemic control value. Columns represent mean ±
standard error of mean. *P < .05 versus control, n = 6 hearts
per group. B, Postischemic recovery of aortic flow after 30
minutes of working mode reperfusion after 5 hours of
hypothermic (7.5°C) storage of hearts arrested and stored
with 22 m mol/L tetrodotoxin + 0.1% methanol (control) or
control + 0.1, 1.0, 10, or 100 m mol/L furosemide. Columns
represent mean ± standard error of mean; *P < .05 versus
control, n = 8 hearts per group.
A
B
Table III. Preischemic function and postischemic
recovery (%) of cardiac function in hearts arrested
and stored with ischemia (control), 16 mmol/L K+ or
22 m mol/L TTX
Group
KH + KH + 
KH 16 mmol/L 22 m mol/L
(control) K+ TTX
Heart rate
beats/min 293 ± 7 281 ± 9 303 ± 20
% recovery 94 ± 2 89 ± 1 97 ± 3
Coronary flow
mL/min 17 ± 1 18 ± 1 17 ± 1
% recovery 75 ± 4 83 ± 6 74 ± 4
Aortic flow
mL/min 59 ± 1 61 ± 2 60 ± 1
% recovery 32 ± 4 39 ± 5 54 ± 4*†
Cardiac output
mL/min 76 ± 2 79 ± 3 76 ± 1
% recovery 42 ± 4 48 ± 5 60 ± 4*
Aortic pressure
cm H2O 177 ± 5 183 ± 4 175 ± 2
% recovery 82 ± 1 82 ± 1 85 ± 1
Stroke volume
mL/beat 0.26 ± 0.01 0.28 ± 0.01 0.26 ± 0.02
% recovery 44 ± 5 53 ± 5 60 ± 3
Stroke work
dyne5 cm/beat 46 ± 2 52 ± 2 46 ± 3
% recovery 37 ± 4 42 ± 5 51 ± 3
KH, Krebs-Henseleit; TTX, tetrodotoxin.
*P = .02 versus control group.
†P < .05 versus 16 mmol/L K+ group.
diate phase of the profile. During phases 1 and 3 of the
profile, K+
e
increased to 11 and 20 mmol/L, respective-
ly, with the onset of phase 3 occurring approximately 90
minutes into the storage period. To our knowledge, this
is the first time that measurement of K+
e
during
hypothermic long-term storage has been reported.
During phase 1 (initial 30 minutes of ischemia) in
hearts arrested with high K+, the increase of K+
e
above
baseline was lower than in the control group of hearts,
as shown in Fig 3, A. This observation is consistent
with the hypothesis that infusion of hyperkalemic solu-
tions, which increase the K+
e
concentration, reduces
the electrochemical gradient and the outward potassi-
um driving force generated by the gradient. Our obser-
vations agree with those of Weiss and Shine,14 who
demonstrated that infusion of a hyperkalemic solution
containing 16 mmol/L K+ into rabbit myocardium also
significantly attenuated K+
e
accumulation during phase
1 (initial 10 minutes) of normothermic global ischemia.
In addition, hearts arrested with tetrodotoxin also
exhibited a reduced level and rate of K+
e
accumulation
during phase 1 compared with the control group of
hearts. Whether this observation suggests that the sodi-
um channel is directly or indirectly involved in the
accumulation of K+
e
during early ischemia is unclear.
During this initial period of ischemia, the opening of
adenosine triphosphate–sensitive potassium channels
(K+ATP channels) has been implicated as contributing
to the accumulation of K+
e
.
16 We3 have shown in a pre-
vious study that levels of ATP and creatine phosphate
are better preserved during the storage period in hearts
arrested with tetrodotoxin than with high K+. Higher
ATP levels during ischemia in tetrodotoxin-arrested
hearts may attenuate the opening of K+ATP channels
during early ischemia and reduce their contribution to
overall K+
e
accumulation.
K+
e
accumulation during the late stages of unprotect-
ed ischemia have been correlated to the onset of irre-
versible injury and cellular uncoupling.17 In the present
study, K+
e
accumulation during the late phase in
tetrodotoxin-treated hearts was lower than in both high
K+–treated and control groups. The time of onset of the
second increase in K+
e
accumulation was also delayed,
indirectly suggesting that tetrodotoxin-induced polar-
ized arrest may be delaying the onset of irreversible
injury and cellular uncoupling, which may account for
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Table IV. Preischemic function and postischemic recovery (%) of cardiac function in hearts arrested and stored
with TTX in combination with various concentrations of furosemide
Group
KH + 22 m mol/L KH + 22 m mol/L KH + 22 m mol/L KH + 22 m mol/L KH + 22 m mol/L
TTX + 0.1% methanol TTX + 0.1 µmol/L TTX + 1.0 m mol/L TTX + 10 m mol/L TTX + 100 m mol/L
(control) furosemide furosemide furosemide furosemide
Heart rate
beats/min 296 ± 6 297 ± 8 295 ± 5 280 ± 8 314 ± 12
% recovery 99 ± 4 95 ± 4 100 ± 3 98 ± 3 94 ± 3
Coronary flow
mL/min 20 ± 1 19 ± 1 19 ± 1 18 ± 1 21 ± 1
% recovery 83 ± 8 76 ± 6 90 ± 4 84 ± 4 85 ± 6
Aortic flow
mL/min 64 ± 2 63 ± 2 63 ± 2 61 ± 2 65 ± 2
% recovery 53 ± 4 56 ± 8 70 ± 2* 69 ± 4* 65 ± 3*
Cardiac output
mL/min 84 ± 2 82 ± 3 82 ± 2 79 ± 3 85 ± 1
% recovery 60 ± 4 61 ± 8 74 ± 2* 72 ± 4* 70 ± 2*
Aortic pressure
cm H2O 193 ± 5 188 ± 3 191 ± 7 190 ± 7 190 ± 4
% recovery 82 ± 3 82 ± 3 86 ± 2 88 ± 1 87 ± 3
Stroke volume
mL/beat 0.3 ± 0.004 0.3 ± 0.01 0.3 ± 0.01 0.3 ± 0.01 0.3 ± 0.01
% recovery 61 ± 5 64 ± 7 75 ± 3* 74 ± 3* 76 ± 5*
Stroke work
dyne5 cm/beat 55 ± 2 52 ± 2 54 ± 3 53 ± 3 52 ± 5
% recovery 51 ± 6 53 ± 7 65 ± 4* 68 ± 5* 67 ± 6*
KH, Krebs-Henseleit; TTX, tetrodotoxin.
*P = .04 versus control group.
the improved recovery of function observed in these
hearts.
K+e and Na+ channel blockers. Mitani and
Shattock15 were able to demonstrate that R56865, a
mixed blocker of the sodium-dependent potassium cur-
rent (IKNa)18 and cardiac sodium channel,19 could
reduce K+
e
accumulation during normothermic global
ischemia. IKNa reportedly becomes activated by con-
centrations of intracellular sodium (Na+i) in excess of
20 mmol/L.20 In this present study, tetrodotoxin was
clearly shown to reduce K+
e
accumulation compared
with high K+–treated and control unprotected hearts. 
Until recently, the effects of selective sodium channel
blockers on K+
e
accumulation during ischemia had not
been studied. Shivkumar and colleagues21 demonstrat-
ed, in the isolated perfused rabbit septum, that 20
m mol/L tetrodotoxin, 1 mmol/L furosemide, 5 m mol/L
ethyl-isopropyl amiloride (EIPA), and 10 m mol/L vera-
pamil reduced K+
e
accumulation during 30 minutes of
normothermic hypoxia. They suggested that for “preser-
vation of both electroneutrality and osmotic balance,”
net Na+i accumulation should reflect net K+e accumula-
tion and that any interventions that reduce Na+i accu-
mulation should also reduce K+
e
accumulation, thereby
constituting a novel central role in the pathogenesis of
ischemia and reperfusion. However, they did not assess
postischemic function after treatment with tetrodotoxin,
furosemide, EIPA, and verapamil, which would have
strengthened their argument. Our observations suggest
that cardioplegic arrest with tetrodotoxin can limit K+
e
accumulation during ischemia, which strongly supports
Shivkumar’s hypothesis that Na+i accumulation may
play an integral role in K+
e
accumulation in the ischemic
heart. Tetrodotoxin has been shown (1) to inhibit the
INaw in sheep Purkinje fibers2 and human ventricular
myocytes22 and (2) to attenuate Na+i accumulation
induced by the sodium channel modulators, veratridine
and lysophosphatidylcholine.23 It is possible, therefore,
that Na+i accumulation may have been attenuated by
tetrodotoxin and subsequently delayed/attenuated IKNa
activation, which may partly explain the overall reduced
K+
e
accumulation compared with high K+–treated and
control hearts. Sodium influx during ischemia, via the
INaw, has previously been suggested to be involved in the
pathogenesis of ischemia/reperfusion injury.24
Dual effects of furosemide on K+e accumulation
during polarized arrest and storage. In this study,
K+
e
accumulation during hypothermic (7.5°C) storage
was reduced by 0.1 and 1.0 m mol/L furosemide; these
observations are consistent with data from Mitani and
Shattock,15 in which 100 m mol/L furosemide was
shown to reduce K+
e
accumulation during normother-
mic (37°C) ischemia. They also demonstrated a slight
augmentation of K+
e
accumulation during the late
phase of their ischemic duration with a higher concen-
tration of furosemide (1.0 m mol/L). This is again con-
sistent with our results in which we observed elevated
K+
e
accumulation at furosemide concentrations of 10
and 100 m mol/L, although we observed this elevation
throughout the K+
e
profile during hypothermic
ischemia. Thus furosemide appears to exert a dose-
dependent dual effect on myocardial K+
e
accumulation.
During steady state conditions, a significant propor-
tion of K+ is thought to enter the cell via Na+/K+/2Cl–
cotransport,25 although the majority of K+ will enter via
the sodium pump. Inhibition of the sodium pump by
profound hypothermia28 (as in the present study) may
increase the proportion of K+ entry via the Na+/K+/2Cl–
cotransporter. This would tend to have the added effect
of increasing Na+i. Thus maximal inhibition of the
Na+/K+/2Cl– cotransporter by high concentrations of
furosemide may result in a net increase in K+
e
accumu-
lation but should also attenuate the increase in Na+.
This may also explain our paradoxic observation of ele-
vated K+
e
together with significant improvement in
myocardial function at the higher concentrations of
furosemide.
At relatively low furosemide concentrations (which
are close to the 50% inhibitory concentration of 5
m mol/L),26 only partial inhibition (up to 50%) of the
cotransporter would occur. It might be expected, there-
fore, that lower concentrations of furosemide elevate
K+
e
accumulation to a lesser extent than the higher
doses of furosemide; in fact, K+
e
accumulation was
reduced to below control levels. Inasmuch as the flux of
both Na+ and K+ via this mechanism is unidirectional,12
it is tempting to speculate that an alternative Na+- and
K+-coupled mechanism is involved in mediating this
dual effect. One possible candidate is the sodium-
dependent potassium current (IKNa).20 Therefore, even
though low concentrations of furosemide (lower than
the published 50% inhibitory concentration) may medi-
ate a small elevation of K+
e
because of reduced K+
influx by Na+/K+/2Cl– cotransport inhibition, the net
K+
e
accumulation is attenuated because of a possible
reduction or delay in the activation of IKNa and its con-
tribution to K+
e
accumulation. Interestingly, the concen-
trations of furosemide that attenuated K+
e
accumulation
in this study have also been shown10 to significantly
attenuate Na+i accumulation during hypothermic stor-
age, thereby supporting our contention that improved
function is related to reducing Na+i accumulation.
Functional recovery and possible mechanisms of
protection. Exposure of myocardial tissue to a hyper-
kalemic (16 mmol/L K+) solution has been shown to
increase intracellular calcium (Ca2+i).6 As a conse-
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quence, energy-consuming mechanisms that maintain
calcium homeostasis may exert a cellular metabolic
demand and accelerate the depletion of energy stores.27
Sternbergh and colleagues8 reported that hearts per-
fused with a solution containing 25 m mol/L tetrodotox-
in demonstrated a significantly lower oxygen con-
sumption than hearts perfused with a high K+ solution.
We3 have previously demonstrated that hearts arrested
with tetrodotoxin had a significantly higher level of
ATP and creatine phosphate at the end of 5 hours of
hypothermic storage.
The consequences of Na+i accumulation become
apparent during reperfusion. The ability of the sodium
pump to efficiently remove accumulated Na+i during
early reperfusion may be attenuated because of reduced
levels of high-energy phosphates28 or the presence of
lipid metabolites.29 As a consequence, Na+i is thought to
be extruded via reverse mode Na+/Ca2+ exchange, result-
ing in a subsequent calcium overload and poor recovery
of function. Tani and Neely11 have shown that the extent
of calcium overload during reperfusion is directly pro-
portional to the degree of Na+i accumulation during
ischemia. In our study, we speculate that tetrodotoxin-
induced polarized arrest reduced Na+i and Ca2+i accu-
mulation in comparison with high K+ depolarized arrest
and that further reduction of Na+i accumulation by
furosemide-mediated inhibition of Na+/K+/2Cl– cotrans-
port during hypothermic polarized arrest may have led to
an additive reduction of calcium overload on reperfusion
and consequent improvement in the recovery of func-
tion. This is supported by our measurements of reduced
ionic movement in the present study, represented by the
reduced K+
e
accumulation in the tetrodotoxin group
(study A). This reduction in ionic imbalance correlates
with improved recovery of function.
In the present study, we have demonstrated that
furosemide exerts dose-dependent beneficial effects
on recovery of function in tetrodotoxin-induced polar-
ized long-term myocardial preservation of the rat
heart. We believe this is due to inhibition of the
Na+/K+/2Cl– cotransport system, which reduces Na+i
accumulation. Rubin and Navon10 have shown, using
23Na nuclear magnetic resonance spectroscopy, that
both furosemide and bumetanide can significantly
attenuate Na+i accumulation. 
In addition, the dose-response effects of furosemide
showed a plateau and a slight reduction in the recovery
of postischemic function; at the highest concentrations
of furosemide investigated, this plateau and trend
toward reduced function was accompanied by higher
K+
e
accumulation in comparison with the hearts stored
with 0.1 and 1.0 m mol/L furosemide. Rubin and col-
leagues30 reported a bell-shaped relationship between
the concentration of furosemide and the recovery of car-
diac function after cardioplegic arrest; at a furosemide
concentration of 1.0 mmol/L, hearts failed to exhibit
any recovery of cardiac function. The elevated K+
e
accumulation observed in our studies may, in part,
explain the apparent toxic effects of higher concentra-
tions of furosemide observed by Rubin and associates.30
Limitations of the studies. One of the main limita-
tions of this study relates to the fact that the hearts were
perfused with crystalloid buffer when blood perfusion
would have been more physiologic. However, a blood-
perfused preparation would have been more difficult
than a crystalloid-perfused preparation, particularly for
a working heart preparation. We used the working heart
preparation specifically because we wished to examine
the ability of the heart to pump against an afterload
after a prolonged preservation period. Most blood-per-
fused rat heart preparations use Langendorff perfusion,
which does not allow pump function to be measured.
Another confounding factor relating to blood perfusion
for this particular study could be the potential hemoly-
sis and the associated increase in extracellular K+,
which would influence our measurements of this para-
meter. Crystalloid perfusion, and the associated low
oncotic pressure that causes myocardial edema, may
also have influenced our inability to detect any
furosemide-induced changes in tissue water content.
Another limitation relates to our inability to directly
examine the mechanism by which we propose that
polarized arrest and inhibition of Na+/K+/2Cl– cotrans-
port influences cardioprotection, namely the attenua-
tion of intracellular Na+ accumulation. Measurement of
Na+i during storage was beyond the scope of this study:
however; it would be of considerable interest for future
studies. We have indirectly demonstrated that ionic
imbalance is important in long-term myocardial preser-
vation by the measurement of K+
e
accumulation.
Although direct extrapolation of the results in the rat
heart to clinical heart transplantation and human organ
storage should be approached with considerable cau-
tion, we do consider that the concepts explored in this
study should be applicable in the human heart. We do
not advocate using tetrodotoxin for human heart
preservation, but other sodium channel blockers that
are in current clinical use (such as lidocaine) may be
useful, and further studies using these compounds
would be of considerable interest.
Conclusions
The observations of this study support our hypothe-
ses (1) that tetrodotoxin-induced polarized arrest atten-
uates ionic changes (lower K+
e
accumulation) and
improves the recovery of cardiac function when com-
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pared with high K+ depolarized arrest and storage and
(2) that Na+/K+/2Cl– cotransport inhibition by
furosemide at an optimal concentration of 1.0 m mol/L
improves preservation conferred by polarized arrest by
further limiting ionic imbalance and reducing K+
e
accu-
mulation during hypothermic storage. However, high
concentrations of furosemide may lead to an elevation
of myocardial K+
e
accumulation and impair the recov-
ery of cardiac function.
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